Sterling Global Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,478
Closed -$288K 33
2018
Q4
$288K Hold
1,478
1.46% 14
2018
Q3
$306K Hold
1,478
1.33% 17
2018
Q2
$273K Hold
1,478
1.76% 18
2018
Q1
$252K Sell
1,478
-500
-25% -$91.8K 1.18% 20
2017
Q4
$344K Hold
1,978
1.45% 15
2017
Q3
$369K Hold
1,978
1.51% 17
2017
Q2
$341K Buy
1,978
+500
+34% +$81.3K 1.63% 15
2017
Q1
$242K Hold
1,478
1.17% 22
2016
Q4
$216K Hold
1,478
0.88% 22
2016
Q3
$247K Hold
1,478
0.92% 22
2016
Q2
$225K Hold
1,478
0.85% 19
2016
Q1
$222K Hold
1,478
1.13% 20
2015
Q4
$240K Hold
1,478
3.81% 15
2015
Q3
$204K Hold
1,478
1.13% 14
2015
Q2
$227K Hold
1,478
0.77% 18
2015
Q1
$238K Hold
1,478
0.73% 18
2014
Q4
$235K Buy
+1,478
New +$230K 0.13% 18

Other funds holding AMGN

Sterling Global Strategies's AMGN Position: Q1 2019 in Review

Sterling Global Strategies sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,478 shares — an estimated $288K sold.

Sterling Global Strategies first reported a position in AMGN in Q4 2014 and held it in 17 quarters. The position peaked at $369K in Q3 2017. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Sterling Global Strategies reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Sterling Global Strategies sold 1,478 Amgen shares in Q1 2019, an estimated $288K.
  • Sterling Global Strategies first reported a position in Amgen in Q4 2014 and held it in 17 quarters.
  • Sterling Global Strategies's Amgen position peaked at $369K in Q3 2017.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.